why choose us

First received: October 06, 2023

Clinical Trial: A Study to Learn About the Amount of the Study Medicine (Sisunatovir) in Blood and Its Safety in Infants and Children With Pneumonia Caused by RSV

Study Status: Completed

Recruit Status: RECRUITING

Condition: Respiratory Syncytial Virus Infections

Study Type: INTERVENTIONAL


Official Title: AN INTERVENTIONAL, PHASE 1b, RANDOMIZED, DOUBLE-BLIND, SPONSOR-OPEN, PLACEBO-CONTROLLED, MULTI-CENTER, DOSE-FINDING STUDY TO EVALUATE SAFETY, TOLERABILITY AND PHARMACOKINETICS OF SISUNATOVIR IN PEDIAT

Brief Summary: The purpose of the study is to learn about the safety and amount of sisunatovir in the blood of infants and children up to age 60 months.These children have Lower Respiratory Tract Infection (LRTI) caused by Respiratory Syncytial Virus (RSV).LRTI is the infection to the lower airways such as lungs.This study will help inform the amount of sisunatovir to be used in future studies of sisunatovir in children.This study is seeking for participants who:Are 1 day to less than or equal to 60 months of ageweigh more than…

Read more